Ono Pharmaceutical Co., Ltd was Shattuck Labs’s largest revenue line in fiscal 2024, bringing in $5.38M of $5.72M (94%).
| Counterparty Name | FY 2024 |
|---|---|
| Ono Pharmaceutical Co., Ltd | $5.38M |
| Immunogen | $343.00K |
| Total | $5.72M |
Shattuck Labs brought in $5.72M from its two revenue lines in fiscal 2024, the year ended December 31, 2024. Ono Pharmaceutical Co., Ltd was the largest at $5.38M (94.0%), ahead of Immunogen at $343.00K (6.0%).
Shattuck Labs (STTK) reports its revenue by counterparty name. In fiscal 2024, Ono Pharmaceutical Co., Ltd was its largest revenue line, bringing in $5.38M (94.0% of the total), followed by Immunogen at $343.00K (6.0%).
Ono Pharmaceutical Co., Ltd was Shattuck Labs' largest revenue line in fiscal 2024, bringing in $5.38M, or 94.0% of the $5.72M total across its two revenue lines.
Every figure comes from Shattuck Labs' annual financial filings, as reported. Each line keeps the name Shattuck Labs gives it, and years follow its fiscal calendar.
Shattuck Labs' revenue by counterparty name goes back to fiscal 2024, with figures through fiscal 2024. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.